Revisions Made to The EDN Tuberculosis Follow-Up Worksheet

Revisions Made to The EDN Tuberculosis Follow-Up Worksheet for Newly-Arrived Persons with Overseas Tuberculosis Classifications

There are changes in the data collection instrument to clarify wording, add additional options for respondents to select, and enhance data collection quality. There are also clarifications made in the second paragraph of the "Purpose and Use of Information Collection" in Supporting Statement A to further clarify information that the data collection instrument collects. In the "Respondent Universe and Sampling Methods" section of Supporting Statement B, there are clarifications made to explain how respondents gain access to and use the Electronic Disease Notification (EDN) system and the data collection instrument. There is an increase from 550 respondents to 1548 respondents due to the increase in the number of individuals throughout the United States requesting access to the EDN system to access medical records for U.S. arrivals and complete the EDN Tuberculosis Follow-Up Worksheet for Newly-Arrived Persons with Overseas Tuberculosis Classifications for U.S. arrivals with TB classifications. There is no change to the burden per respondent to complete a follow-up form. As noted in Supporting Statement A, the calculated estimated annual cost to the federal government for this project was updated from $139,500 to $137,417 per year to more accurately reflect current costs of staff.

Field of Revision	Revision Made	Reason for Revision
C3a	Added “in the U.S.” after “Was IGRA performed”	To make the language consistent with C2a “Was TST administered in the U.S.?”
C3c	Changed "other, (specify):" to "Other, specify:"	To make the language consistent throughout the data collection instrument each time “Other, specify” is listed
C9b	Changed “At designated DOT site” to “At DGMQ-designated-DOT site” and “At non-DGMQ-designated DOT site”	To make the language consistent with other Department of State overseas medical forms that are in use
C9f	Changed check boxes from "Yes” and “No" to "Standard TB treatment" and "Non-standard TB treatment." Moved C9f to the top of the right-side column.	To provide more clarity regarding what “Yes” and “No” mean
C11b	Added “Undocumented/unverified treatment” checkbox option. Changed “Other, please specify” to “Other, specify”	Based on data analysis of how respondents answered C11b since this data collection instrument’s use after the last OMB approval, this check box is added to reflect a commonly typed in response in the “other, specify” field. “Other, please specify” is changed to “Other, specify” to make the language consistent throughout the data collection instrument each time “other, specify” is listed.
Field of Revision	Revision Made	Reason for Revision
D3	Added “Culture confirmed Yes/No” field underneath “Class 3 – TB, TB disease” check box options	To enhance the quality of data collection by requesting additional data
E5a	Changed “U.S. treatment completed” to "U.S. treatment completion status and dates" Changed check box options from “Yes” and “No” to “Completed” and “Treatment discontinued/stopped” with date fields. Added “Treatment ongoing” checkbox option.	To enhance the quality of data collection by requesting additional data and listing possibilities to clarify treatment ending options
E5b	Changed “If No” to “If treatment discontinued/stopped”	To match the check box option selection in E5a.
E6	Removed E6 “Date therapy stopped” and removed "Specify reason therapy stopped" (open text field).	The addition of “Treatment discontinued/stopped” in E5a replaces “Date therapy stopped.” “Specify reason therapy stopped” is removed as it is repetitive of E5b.

Restricted Use/Any User (No encryption)